{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:00:09Z","timestamp":1773270009960,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007684","name":"Ministry of Education and Science of Ukraine","doi-asserted-by":"crossref","award":["0118U000244"],"award-info":[{"award-number":["0118U000244"]}],"id":[{"id":"10.13039\/501100007684","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007684","name":"Ministry of Education and Science of Ukraine","doi-asserted-by":"crossref","award":["0119U100331"],"award-info":[{"award-number":["0119U100331"]}],"id":[{"id":"10.13039\/501100007684","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11010-021-04144-y","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T11:03:28Z","timestamp":1617275008000},"page":"3021-3035","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Suppression of systemic inflammation and signs of acute and chronic cholangitis by multi-kinase inhibitor 1-(4-Cl-benzyl)-3-chloro-4-(CF3-phenylamino)-1H-pyrrole-2,5-dione"],"prefix":"10.1007","volume":"476","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1296-1007","authenticated-orcid":false,"given":"Halyna","family":"Kuznietsova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iryna","family":"Byelinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Dziubenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oksana","family":"Lynchak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demyd","family":"Milokhov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Khilya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataliya","family":"Finiuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Klyuchivska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rostyslav","family":"Stoika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volodymyr","family":"Rybalchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"4144_CR1","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/hep.24247","volume":"53","author":"NA Molodecky","year":"2011","unstructured":"Molodecky NA, Kareemi H, Parab R, Barkema HW, Quan H, Myers RP, Kaplan GG (2011) Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology 53:1590\u20131599","journal-title":"Hepatology"},{"key":"4144_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"GM Hirschfield","year":"2017","unstructured":"Hirschfield GM, Beuers U, Corpechot C et al (2017) EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol 67:145\u2013172","journal-title":"J Hepatol"},{"issue":"29","key":"4144_CR3","doi-asserted-by":"publisher","first-page":"26757","DOI":"10.18632\/oncotarget.5610","volume":"6","author":"GQ Zhu","year":"2015","unstructured":"Zhu GQ, Shi KQ, Huang GQ, Wang LR, Lin YQ, Braddock M (2015) A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis. Oncotarget 6(29):26757\u201326769","journal-title":"Oncotarget"},{"issue":"4 Pt B","key":"4144_CR4","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.bbadis.2018.01.014","volume":"1864","author":"JM Banales","year":"2018","unstructured":"Banales JM, Marzioni M, LaRusso NF, Jansen P (2018) Cholangiocytes in health and disease: From basic science to novel treatments. Biochim Biophys Acta Mol Basis Dis. 1864(4 Pt B):1217\u20131219","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"issue":"3","key":"4144_CR5","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/jcm9030754","volume":"9","author":"C Vl\u0103du\u0163","year":"2020","unstructured":"Vl\u0103du\u0163 C, Cioc\u00eerlan M, Bilous D et al (2020) An overview on primary sclerosing cholangitis. J Clin Med 9(3):754","journal-title":"J Clin Med"},{"issue":"4 Pt B","key":"4144_CR6","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.bbadis.2017.08.020","volume":"1864","author":"BK Chung","year":"2018","unstructured":"Chung BK, Karlsen TH, Folseraas T (2018) Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma. Biochim Biophys Acta Mol Basis Dis. 1864(4 Pt B):1390\u20131400","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"issue":"1","key":"4144_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4291\/wjgp.v10.i1.1","volume":"10","author":"IG Rajapaksha","year":"2019","unstructured":"Rajapaksha IG, Angus PW, Herath CB (2019) Current therapies and novel approaches for biliary diseases. World J Gastrointest Pathophysiol 10(1):1\u201310","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"6","key":"4144_CR8","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134(6):1655\u20131669","journal-title":"Gastroenterology"},{"key":"4144_CR9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3389\/fphar.2015.00300","volume":"6","author":"K Qu","year":"2016","unstructured":"Qu K, Huang Z, Lin T et al (2016) New insight into the anti-liver fibrosis effect of multitargeted tyrosine kinase inhibitors: from molecular target to clinical trials. Front Pharmacol 6:300","journal-title":"Front Pharmacol"},{"issue":"1","key":"4144_CR10","first-page":"39","volume":"5","author":"G Dubinina","year":"2007","unstructured":"Dubinina G, Golovach S, Kozlovsky V, Tolmachov AO, Volovenko YuM (2007) Antiproliferative action of the new derivatives of l-(4-R-benzyl)-3-R1-4-(R2-phenylamino)-1H-pyrrol-2,5-dione. J Organ Pharm Chem 5(1):39\u201349","journal-title":"J Organ Pharm Chem"},{"issue":"1","key":"4144_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s40203-019-0051-2","volume":"7","author":"HM Kuznietsova","year":"2019","unstructured":"Kuznietsova HM, Hurmach VV, Bychko AV et al (2019) Synthesis and biological activity of 4-amino-3-chloro-1H-pyrrole-2,5-diones. In Silico Pharmacol 7(1):2","journal-title":"In Silico Pharmacol"},{"issue":"5","key":"4144_CR12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/1061186X.2019.1703189","volume":"28","author":"H Kuznietsova","year":"2020","unstructured":"Kuznietsova H, Dziubenko N, Byelinska I et al (2020) Pyrrole derivatives as potential anti-cancer therapeutics: synthesis, mechanisms of action, safety. J Drug Target 28(5):547\u2013563","journal-title":"J Drug Target"},{"issue":"3","key":"4144_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.15407\/ubj85.03.074","volume":"85","author":"HM Kuznietsova","year":"2013","unstructured":"Kuznietsova HM, Lynchak OV, Danylov MO, Kotlyar IP, Rybalchenko VK (2013) Effect of dihydropyrrole and maleimide derivatives on the state of the liver and colon in normal rats and those with colorectal carcinogenesis induced by dimethylhydrazine. Ukr Biochem J 85(3):74\u201384","journal-title":"Ukr Biochem J"},{"key":"4144_CR14","doi-asserted-by":"publisher","first-page":"2145753","DOI":"10.1155\/2016\/2145753","volume":"2016","author":"HM Kuznietsova","year":"2016","unstructured":"Kuznietsova HM, Yena MS, Kotlyar IP, Ogloblya OV, Rybalchenko VK (2016) Antiinflammatory effects of protein kinase inhibitor pyrrol derivate. Sci World J 2016:2145753","journal-title":"Sci World J"},{"key":"4144_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.15407\/dopovidi2018.05.083","volume":"5","author":"HM Kuznietsova","year":"2018","unstructured":"Kuznietsova HM, Dziubenko NV, Lynchak OV et al (2018) Hepatoprotective effect of protein kinase inhibitor 1-(4-Cl-benzyl)-3-chloro-4-(CF3-phenylamino)-1H-pyrrole-2,5-dione on rat acute cholangitis. Dopov Nac akad nauk Ukr 5:83\u201390","journal-title":"Dopov Nac akad nauk Ukr"},{"key":"4144_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/09629350020027609","volume":"9","author":"H Tch\u00f3rzewski","year":"2000","unstructured":"Tch\u00f3rzewski H, Krasomski G, Biesiada L, G\u0142owacka E, Banasik M, Lewkowicz P (2000) IL-12, IL-6 and IFN-\u03b3 production by lymphocytes of pregnant women with rheumatoid arthritis remission during pregnancy. Mediators Inflamm 9:289\u2013293","journal-title":"Mediators Inflamm"},{"issue":"1","key":"4144_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.homp.2014.10.001","volume":"104","author":"S Arora","year":"2015","unstructured":"Arora S, Tandon S (2015) DNA fragmentation and cell cycle arrest: a hallmark of apoptosis induced by Ruta graveolens in human colon cancer cells. Homeopathy 104(1):36\u201347","journal-title":"Homeopathy"},{"issue":"1","key":"4144_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ymeth.2009.02.016","volume":"48","author":"W Liao","year":"2009","unstructured":"Liao W, McNutt MA, Zhu WG (2009) The comet assay: a sensitive method for detecting DNA damage in individual cells. Methods 48(1):46\u201353","journal-title":"Methods"},{"issue":"1","key":"4144_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/CAD.0000000000000686","volume":"30","author":"N Finiuk","year":"2019","unstructured":"Finiuk N, Klyuchivska O, Ivasechko I et al (2019) Proapoptotic effects of novel thiazole derivative on human glioma cells. Anticancer Drugs 30(1):27\u201337","journal-title":"Anticancer Drugs"},{"key":"4144_CR20","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jhep.2014.02.006","volume":"60","author":"P Fickert","year":"2014","unstructured":"Fickert P, Pollheimer MJ, Beuers U et al (2014) Characterization of animal models for primary sclerosing cholangitis (PSC). J Hepatol 60:1290\u20131303","journal-title":"J Hepatol"},{"issue":"6","key":"4144_CR21","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2131\/jts.42.715","volume":"42","author":"MK Bothe","year":"2017","unstructured":"Bothe MK, Meyer C, Mueller U, Queudot JC, Roger V, Harleman J, Westphal M (2017) Characterization of a rat model of moderate liver dysfunction based on alpha-naphthylisothiocyanate-induced cholestasis. J Toxicol Sci 42(6):715\u201321","journal-title":"J Toxicol Sci"},{"key":"4144_CR22","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/1472-6882-13-375","volume":"13","author":"XQ Liu","year":"2013","unstructured":"Liu XQ, Hu XJ, Xu HX, Zeng XY (2013) Xiaochaihu Decoction attenuates the vicious circle between the oxidative stress and the ALP inactivation through LPS-catecholamines interactions in gut, liver and brain during CCI4+ethanol-induced mouse HCC. BMC Complement Alter Med 13:375","journal-title":"BMC Complement Alter Med"},{"key":"4144_CR23","volume-title":"Histological and histochemical methods: theory and practice","author":"J Kiernan","year":"2008","unstructured":"Kiernan J (2008) Histological and histochemical methods: theory and practice, 4th edn. Cold Spring Harbor Laboratory Press, New York","edition":"4"},{"issue":"4","key":"4144_CR24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","volume":"47","author":"ZD Goodman","year":"2007","unstructured":"Goodman ZD (2007) Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 47(4):598\u2013607","journal-title":"J Hepatol"},{"issue":"6","key":"4144_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22(6):696\u2013699","journal-title":"J Hepatol"},{"key":"4144_CR26","volume-title":"liver biopsy","author":"G Shiha","year":"2011","unstructured":"Shiha G, Zalata K (2011) Ishak versus METAVIR: terminology, convertibility and correlation with laboratory changes in chronic hepatitis C. In: Takahashi H (ed) liver biopsy. InTech, London"},{"key":"4144_CR27","volume-title":"Hematology","author":"Y Alemu","year":"2006","unstructured":"Alemu Y, Atomsa A, Sahlemariam Z (2006) Hematology. EPHTI, Jimma"},{"issue":"1","key":"4144_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/0168-8278(89)90073-1","volume":"9","author":"JA Snook","year":"1989","unstructured":"Snook JA, Chapman RW, Sachdev GK, Heryet A, Kelly PMA, Fleming KA, Jewell DP (1989) Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis. J Hepatol 9(1):36\u201341","journal-title":"J Hepatol"},{"issue":"4","key":"4144_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.15407\/ubj92.04.055","volume":"92","author":"NS Finiuk","year":"2020","unstructured":"Finiuk NS, Ivasechko II, Klyuchivska OYu et al (2020) Cytotoxic action of maleimide derivative 1-(4-Cl-benzyl)-3-chloro-4-(CF3-phenylamino)-1H-pyrrole-2,5-dione toward mammalian tumor cells and its capability to interact with DNA. Ukr Biochem J 92(4):55\u201362","journal-title":"Ukr Biochem J"},{"issue":"7","key":"4144_CR30","doi-asserted-by":"publisher","first-page":"E2336","DOI":"10.3390\/ijms21072336","volume":"21","author":"S Moertl","year":"2020","unstructured":"Moertl S, Buschmann D, Azimzadeh O et al (2020) Radiation exposure of peripheral mononuclear blood cells alters the composition and function of secreted extracellular vesicles. Int J Mol Sci 21(7):E2336","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4144_CR31","first-page":"14","volume":"112","author":"E Hollville","year":"2006","unstructured":"Hollville E, Martin SJ (2006) Measuring Apoptosis by Microscopy and Flow Cytometry. Curr Proto Immunol 112(1):14\u201338","journal-title":"Curr Proto Immunol"},{"key":"4144_CR32","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"T Karlsen","year":"2017","unstructured":"Karlsen T, Folseraas T, Thorburn D, Vesterhus M (2017) Primary sclerosing cholangitis\u2014a comprehensive review. J Hepatol 67:1298\u20131323","journal-title":"J Hepatol"},{"issue":"2","key":"4144_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3727\/105221616X692568","volume":"17","author":"C Hall","year":"2017","unstructured":"Hall C, Sato K, Wu N et al (2017) Regulators of cholangiocyte proliferation. Gene Expr 17(2):155\u2013171","journal-title":"Gene Expr"},{"key":"4144_CR34","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1017\/S1462399409000994","volume":"11","author":"S Glaser","year":"2009","unstructured":"Glaser S, Gaudio E, Miller T, Alvaro D, Alpini G (2009) Cholangiocyte proliferation and liver fibrosis. Expert Rev Mol Med 11:E7","journal-title":"Expert Rev Mol Med"},{"issue":"5","key":"4144_CR35","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/hep.21143","volume":"43","author":"L Fabris","year":"2006","unstructured":"Fabris L, Cadamuro M, Fiorotto R et al (2006) Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases. Hepatology 43(5):1001\u20131012","journal-title":"Hepatology"},{"issue":"4","key":"4144_CR36","doi-asserted-by":"publisher","first-page":"e0125793","DOI":"10.1371\/journal.pone.0125793","volume":"10","author":"CE Trussoni","year":"2015","unstructured":"Trussoni CE, Tabibian JH, Splinter PL, O\u2019Hara SP (2015) Lipopolysaccharide (LPS)-induced biliary epithelial cell NRas activation requires epidermal growth factor receptor (EGFR). PLoS ONE 10(4):e0125793","journal-title":"PLoS ONE"},{"issue":"2","key":"4144_CR37","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/hep.29350","volume":"67","author":"A Pellat","year":"2018","unstructured":"Pellat A, Vaquero J, Fouassier L (2018) Role of ErbB\/HER family of receptor tyrosine kinases in cholangiocyte biology. Hepatology 67(2):762\u2013773","journal-title":"Hepatology"},{"key":"4144_CR38","doi-asserted-by":"publisher","first-page":"8323747","DOI":"10.1155\/2016\/8323747","volume":"2016","author":"JD Schumacher","year":"2016","unstructured":"Schumacher JD, Guo GL (2016) Regulation of hepatic stellate cells and fibrogenesis by fibroblast growth factors. Biomed Res Int 2016:8323747","journal-title":"Biomed Res Int"},{"issue":"4 Pt B","key":"4144_CR39","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.bbadis.2017.07.026","volume":"1864","author":"M Pinzani","year":"2018","unstructured":"Pinzani M, Luong TV (2018) Pathogenesis of biliary fibrosis. Biochim Biophys Acta Mol Basis Dis. 1864(4 Pt B):1279\u20131283","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"issue":"1","key":"4144_CR40","first-page":"79","volume":"44","author":"SH Liu","year":"2019","unstructured":"Liu SH, Chen XF, Xie ZB, Zhou J (2019) EGFR monoclonal antibody panitumumab inhibits chronic proliferative cholangitis by downregulating EGFR. Int J Mol Med 44(1):79\u201388","journal-title":"Int J Mol Med"},{"issue":"6","key":"4144_CR41","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1002\/hep.21921","volume":"46","author":"S Tugues","year":"2007","unstructured":"Tugues S, Fernandez-Varo G, Mu\u00f1oz-Luque J et al (2007) Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats. Hepatology 46(6):1919\u20131926","journal-title":"Hepatology"},{"issue":"4","key":"4144_CR42","first-page":"2909","volume":"16","author":"D Lou","year":"2018","unstructured":"Lou D, Han J, Zhou L et al (2018) Fibroblast growth factor receptor 1 antagonism attenuates lipopolysaccharide-induced activation of hepatic stellate cells via suppressing inflammation. Exp Ther Med 16(4):2909\u20132916","journal-title":"Exp Ther Med"},{"issue":"6","key":"4144_CR43","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1042\/CS20181123","volume":"133","author":"WT Ma","year":"2019","unstructured":"Ma WT, Chen DK (2019) Immunological abnormalities in patients with primary biliary cholangitis. Clin Sci (Lond) 133(6):741\u2013760","journal-title":"Clin Sci (Lond)"},{"key":"4144_CR44","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.3389\/fimmu.2019.02035","volume":"10","author":"TS Kapellos","year":"2019","unstructured":"Kapellos TS, Bonaguro L, Gem\u00fcnd I, Reusch N, Saglam A, Hinkley ER, Schultze JL (2019) Human monocyte subsets and phenotypes in major chronic inflammatory diseases. Front Immunol 10:2035","journal-title":"Front Immunol"},{"key":"4144_CR45","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436\u2013444","journal-title":"Nature"},{"issue":"2","key":"4144_CR46","first-page":"1898","volume":"7","author":"IV Byelinska","year":"2016","unstructured":"Byelinska IV, Garmanchuk LV, Shelest DV, Rybalchenko TV, Khranovska NM (2016) Effect of maleimide derivative, protein kinases inhibitor, on the morphofunctional state of human neoplastic monoblast cell line U-937. Res J Pharm Biol Chem Sci 7(2):1898\u20131905","journal-title":"Res J Pharm Biol Chem Sci"},{"issue":"3","key":"4144_CR47","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3103\/S0095452715030044","volume":"49","author":"IV Byelinska","year":"2015","unstructured":"Byelinska IV, Lynchak OV, Rybalchenko TV, Yablonska SV, Bahurynska OM, Rybalchenko VK (2015) Morphofunctional parameters of blood cells of a rat with 1,2-dimethylhydrazine-induced colon carcinogenesis. Cytol Genet 49(3):158\u2013164","journal-title":"Cytol Genet"},{"issue":"4","key":"4144_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.15407\/fz61.04.071","volume":"61","author":"IV Byelinska","year":"2015","unstructured":"Byelinska IV, Lynchak OV, Tsyvinska SM, Rybalchenko VK (2015) Morphofunctional state of blood cells after chronic exposure of the protein kinases inhibitor maleimide derivative. Fiziol Zh 61(4):71\u201377","journal-title":"Fiziol Zh"},{"issue":"5","key":"4144_CR49","doi-asserted-by":"publisher","first-page":"470","DOI":"10.2174\/138920009788897975","volume":"10","author":"JT Hartmann","year":"2009","unstructured":"Hartmann JT, Haap M, Kopp HG, Lipp HP (2009) Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effects. Curr Drug Metab 10(5):470\u2013481","journal-title":"Curr Drug Metab"},{"key":"4144_CR50","doi-asserted-by":"publisher","first-page":"815105","DOI":"10.1155\/2013\/815105","volume":"2013","author":"Y Maor","year":"2013","unstructured":"Maor Y, Malnick S (2013) Liver injury induced by anticancer chemotherapy and radiation therapy. Int J Hepatol 2013:815105","journal-title":"Int J Hepatol"},{"key":"4144_CR51","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3389\/fphar.2017.00367","volume":"8","author":"F Paech","year":"2017","unstructured":"Paech F, Bouitbir J, Kr\u00e4henb\u00fchl S (2017) Hepatocellular toxicity associated with tyrosine kinase inhibitors: mitochondrial damage and inhibition of glycolysis. Front Pharmacol 8:367","journal-title":"Front Pharmacol"},{"issue":"2","key":"4144_CR52","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/cld.810","volume":"14","author":"S Sarcognato","year":"2019","unstructured":"Sarcognato S, Garcia-Lezana T, Villanueva A (2019) Mechanisms of action of drugs effective in hepatocellular carcinoma. Clin Liver Dis 14(2):62\u201365","journal-title":"Clin Liver Dis"},{"issue":"7","key":"4144_CR53","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s40264-013-0048-4","volume":"36","author":"RR Shah","year":"2013","unstructured":"Shah RR, Morganroth J, Shah DR (2013) Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives. Drug Saf 36(7):491\u2013503","journal-title":"Drug Saf"},{"issue":"5","key":"4144_CR54","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2217\/pgs.13.24","volume":"14","author":"CF Spraggs","year":"2013","unstructured":"Spraggs CF, Hu C-F, Hunt CM (2013) Genetic characterization to improve interpretation and clinical management of hepatotoxicity caused by tyrosine kinase inhibitors. Pharmacogenomics 14(5):541\u2013554","journal-title":"Pharmacogenomics"},{"issue":"377","key":"4144_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.tox.2016.12.009","volume":"15","author":"N Joshi","year":"2017","unstructured":"Joshi N, Kopec AK, Cline-Fedewa H, Luyendyk JP (2017) Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis. Toxicology 15(377):73\u201380","journal-title":"Toxicology"},{"key":"4144_CR56","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1046\/j.1365-2249.1998.00629.x","volume":"113","author":"S Gupta","year":"1998","unstructured":"Gupta S, Aggarwal S, Nguyen T (1998) Increased spontaneous apoptosis in T lymphocytes in DiGeorge anomaly. Clin Exp Immunol 113:65\u201371","journal-title":"Clin Exp Immunol"},{"key":"4144_CR57","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1182\/blood.V80.11.2920.2920","volume":"80","author":"MA Brach","year":"1992","unstructured":"Brach MA, Devos S, Gruss HJ, Herrmann F (1992) Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 80:2920\u20132924","journal-title":"Blood"},{"key":"4144_CR58","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2131\/jts.27.191","volume":"27","author":"K Nagami","year":"2002","unstructured":"Nagami K, Kawashima Y, Kuno H, Kemi M, Matsumoto H (2002) In vitro cytotoxicity assay to screen compounds for apoptosis-inducing potential on lymphocytes and neutrophils. J Toxicol Sci 27:191\u2013203","journal-title":"J Toxicol Sci"},{"issue":"11","key":"4144_CR59","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.cellbi.2006.06.016","volume":"30","author":"D Baskic","year":"2006","unstructured":"Baskic D, Popovic S, Ristic P, Arsenijevic N (2006) Analysis of cycloheximide-induced apoptosis in human leukocytes: fluorescence microscopy using annexin V\/propidium iodide versus acridin orange\/ethidium bromide. Cell Biol Int 30(11):924\u2013932","journal-title":"Cell Biol Int"},{"key":"4144_CR60","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3389\/fonc.2019.00635","volume":"9","author":"IS Mohiuddin","year":"2019","unstructured":"Mohiuddin IS, Kang MH (2019) DNA-PK as an emerging therapeutic target in cancer. Front Oncol 9:635","journal-title":"Front Oncol"},{"key":"4144_CR61","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fphar.2013.00005","volume":"4","author":"D Davidson","year":"2013","unstructured":"Davidson D, Amrein L, Panasci L, Aloyz R (2013) Small molecules, inhibitors of DNA-PK, targeting DNA repair, and beyond. Front Pharmacol 4:5","journal-title":"Front Pharmacol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04144-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-021-04144-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04144-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T15:22:57Z","timestamp":1667056977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-021-04144-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["4144"],"URL":"https:\/\/doi.org\/10.1007\/s11010-021-04144-y","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"15 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experiments with animals were conducted in compliance with bioethics principles, legislative norms, and provisions of the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010\/63\/EU for animal experiments, adopted by the First National Bioethics Congress (Kyiv, 2001), and approved by Ethics Committee of Institute of Biology and Medicine of Taras Shevchenko National University of Kyiv (Protocol No. 35 dated by 19 Apr 2017).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study protocol for using human lymphocytes of healthy adult was approved by the Ethics Committee of the Institute of Cell Biology, National Academy of Sciences of Ukraine (protocol no. 2 dated by 27 Jan 2019).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and\/or animal participants"}}]}}